Groowe Groowe / Newsroom / BNTX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BNTX News

BioNTech SE American Depositary Share

Patient Safety Launches Nationwide

prnewswire.com
MSFT UNH HCA AMZN CVS GEHC BIO MDLZ SYK BMY PFE JNJ ABBV AMGN GILD REGN BIIB MRNA BNTX XRAY ISRG TMDX HOLX EW COO LH DGX CTAS BRKR VRTX ALGN MDT BAX ZBH VRSN ADBE IBM ORCL HPQ DELL CSCO INTC QCOM MU AMAT LRCX KLAC ADI NXPI MCHP ON NVDA AMD GOOG META AAPL AVGO TSLA

BioNTech Announces New ADS Repurchase Program

globenewswire.com
BNTX

Mana.bio Announces Strategic Leadership Additions and Upcoming Presentation at ASGCT 2026 Annual Meeting

prnewswire.com
BNTX MRNA PFE SNY

BioNTech Announces First Quarter 2026 Financial Results and Corporate Update

globenewswire.com
BNTX PFE BMY

Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight

globenewswire.com
TMO CRL REGN BNTX MRNA GSK SCLX

Global Perfusion Systems Market to Register Incremental Growth at a CAGR of ~5% by 2034 | DelveInsight

globenewswire.com
MDT LIVN BSX THC AMGN AZN PFE JNJ MRNA BMY GILD REGN TEVA CL PG KO PEP DIS NVDA GOOG AMZN MSFT AAPL TSLA META CRM ADBE NFLX INTC AMD QCOM CMCSA T VZ IBM ORCL CSCO ACN HON GE BA CAT XOM CVX JPM BAC WFC C GS MS AXP V MA HD MCD SBUX COST WMT TGT LOW CVS UNH CI ETSY ROKU PYPL MELI EBAY BABA JD PDD NTES BIDU TM SONY SAP AIR ASML BNTX NVO BP FCX BHP RIO VALE NKE LULU UA CROX NOC GD LMT RTX AVGO AMAT LRCX MU NXPI MRVL SNPS CDNS VRTX BIIB LLY ABBV MRK CHTR CMG SIRI GEHC GSK SNY MREO

BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026

globenewswire.com
BNTX

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

globenewswire.com
BNTX

FairJourney Bio Opens Cryo-EM Structural Biology Facility in San Diego

businesswire.com
PFE BNTX MRNA

DualityBio gibt Annahme des Zulassungsantrags für Trastuzumab Pamirtecan zur Behandlung von nicht resezierbarem oder metastasiertem HER2-positivem Brustkrebs bei erwachsenen Patienten durch die chinesische NMPA bekannt USA - Deutsch USA - English USA -

prnewswire.com
BNTX